Thyroid transcription factor-1 also expressed 100% of differentiated follicular tumours including follicular adenoma, follicular carcinoma and papillary carcinoma, but only 25% of undifferentiated carcinoma of the thyroid (Katoh et al, 2000). Here, NKX2-1 is linked to follicular thyroid adenoma.